Business

Akoustis to Attend the 12th Annual Craig-Hallum Alpha Select Conference on November 16, 2021

Charlotte, N.C., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer

articleAktis Oncology, Inc.November 9, 20215/company/aktis-oncology-inc-common-stock/news/akoustis-to-attend-the-12th-annual-craig-hallum-alpha-select-conference-on-november
Akoustis to Attend the 12th Annual Craig-Hallum Alpha Select Conference on November 16, 2021

About this update from Aktis Oncology, Inc.

[{"type":"text","content":"Charlotte, N.C., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today that senior management will attend the 12th Annual Craig-Hallum Alpha Select Conference on November 16, 2021. Meetings will take place virtually given the ongoing call for social distancing due to the Covid-19 pandemic. Investors that would like to schedule a meeting with Akoustis management should contact their Craig-Hallum representative or Akoustis’ investor relations at [email protected]. Akoustis is actively delivering volume production of its WiFi 6 tandem filter solutions, shipping multiple 5G small cell XBAW™ filter solutions, delivering initial designs of its new 5G mobile filter solutions to multiple customers and is now entering the market with its new WiFi 6E coexistence XBAW™ filter solutions. Given the rapidly growing sales funnel activity as well as ongoing interaction with customers regarding expected ramps in 5G mobile, WiFi 6 and WiFi 6E in calendar 2022, the Company plans to increase the annual production capacity at its New York fab by the end of calendar 2021 to approximately 500 million filters per year. About Akoustis Technologies, Inc. Akoustis® (http://www.akoustis.com/) is a high-tech BAW RF filter solutions company that is pioneering next-generation materials science and MEMS wafer manufacturing to address the market requirements for improved RF filters - targeting higher bandwidth, higher operating frequencies and higher output power compared to incumbent polycrystalline BAW technology deployed today. The Company utilizes its proprietary and patented XBAWTM manufacturing process to produce bulk acoustic wave RF filters for mobile and other wireless markets, which facilitate signal acquisition and accelerate band performance between the antenna and digital back end. Superior performance is driven by the significant advances of poly-crystal, high-purity and single-crystal piezoelectric materials and the resonator-filter process technology which enables optimal trade-offs between critical power, frequency and bandwidth performance specifications. Akoustis plans to service the fast growing multi-billion-dollar RF filter market us...

More updates from Aktis Oncology, Inc.